Search research articles
Contact Us
Filters
Showing results (61-70 of 167) with videos related to
Page
of 17
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 14, 2014
False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer
Anya Litvak, Andrea Cercek, Neil Segal, et al.
Epigenetics
|
May 8, 2024
Evaluating the utility of <i>ZNF331</i> promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance)
Elizabeth S Nakasone, Tyler J Zemla, Ming Yu, et al.
Gastrointestinal Cancer Research : GCR
|
October 23, 2013
Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer
Haifa Dbouk, Hana Ajouz, Ali Shamseddine, et al.
JCO Oncology Practice
|
June 20, 2022
A Randomized Trial Evaluating Patient Experience and Preference Between Octreotide Long-Acting Release and Lanreotide for Treatment of Well-Differentiated Neuroendocrine Tumors
Nitya Raj, Elizabeth Cruz, Sarah O'Shaughnessy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 2008
ACR Appropriateness Criteria on resectable rectal cancer: expert panel on radiation oncology--rectal/anal cancer
W Warren Suh, A William Blackstock, Joseph Herman, et al.
The Oncologist
|
April 27, 2005
HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum
Román Pérez-Soler, Jean Pierre Delord, Allan Halpern, et al.
Gastrointestinal Cancer Research : GCR
|
August 13, 2013
A 40-year-old woman with locally advanced rectal cancer and a solitary liver metastasis
Carla Hajj, Karyn Goodman, David Kelsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2008
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer
Jim Cassidy, Stephen Clarke, Eduardo Díaz-Rubio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors
Gary K Schwartz, Eileen O'Reilly, David Ilson, et al.
Current Problems in Cancer
|
June 15, 2010
ACR Appropriateness Criteria: rectal cancer-metastatic disease at presentation
Joseph Herman, Wells Messersmith, W Warren Suh, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 167) with videos related to
Sort By:
Page
of 17
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 14, 2014
False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer
Anya Litvak, Andrea Cercek, Neil Segal, et al.
Epigenetics
|
May 8, 2024
Evaluating the utility of <i>ZNF331</i> promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance)
Elizabeth S Nakasone, Tyler J Zemla, Ming Yu, et al.
Gastrointestinal Cancer Research : GCR
|
October 23, 2013
Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer
Haifa Dbouk, Hana Ajouz, Ali Shamseddine, et al.
JCO Oncology Practice
|
June 20, 2022
A Randomized Trial Evaluating Patient Experience and Preference Between Octreotide Long-Acting Release and Lanreotide for Treatment of Well-Differentiated Neuroendocrine Tumors
Nitya Raj, Elizabeth Cruz, Sarah O'Shaughnessy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 2008
ACR Appropriateness Criteria on resectable rectal cancer: expert panel on radiation oncology--rectal/anal cancer
W Warren Suh, A William Blackstock, Joseph Herman, et al.
The Oncologist
|
April 27, 2005
HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum
Román Pérez-Soler, Jean Pierre Delord, Allan Halpern, et al.
Gastrointestinal Cancer Research : GCR
|
August 13, 2013
A 40-year-old woman with locally advanced rectal cancer and a solitary liver metastasis
Carla Hajj, Karyn Goodman, David Kelsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2008
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer
Jim Cassidy, Stephen Clarke, Eduardo Díaz-Rubio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors
Gary K Schwartz, Eileen O'Reilly, David Ilson, et al.
Current Problems in Cancer
|
June 15, 2010
ACR Appropriateness Criteria: rectal cancer-metastatic disease at presentation
Joseph Herman, Wells Messersmith, W Warren Suh, et al.
Page
of 17